Comparison of miniaturized time-resolved fluorescence resonance energy transfer and enzyme-coupled luciferase high-throughput screening assays to discover inhibitors of Rho-kinase II (ROCK-II)

Thomas Schröter, Dmitriy Minond, Amiee Weiser, Chinh Dao, Jeff Habel, Timothy Spicer, Peter Chase, Pierre Baillargeon, Louis Scampavia, Stephan C Schuerer, Caty Chung, Chris Mader, Mark Southern, Nicholas Tsinoremas, Philip LoGrasso, Peter Hodder

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Kinases are important drug discovery targets for a wide variety of therapeutic indications; consequently, the measurement of kinase activity remains a common high-throughput screening (HTS) application. Recently, enzyme-coupled luciferase-kinase (LK) format assays have been introduced. This format measures luminescence resulting from metabolism of adenosine triphosphate (ATP) via a luciferin/luciferase-coupled reaction. In the research presented here, 1536-well format time-resolved fluorescence resonance energy transfer (TR-FRET) and LK assays were created to identify novel Rho-associated kinase II (ROCK-II) inhibitors. HTS campaigns for both assays were conducted in this miniaturized format. It was found that both assays were able to consistently reproduce the expected pharmacology of inhibitors known to be specific to ROCK-II (fasudil IC50: 283 ± 27 nM and 336 ± 54 nM for TR-FRET and LK assays, respectively; Y-27632 IC50: 133 ± 7.8 nM and 150 ± 22 nM for TR-FRET and LK assays, respectively). In addition, both assays proved robust for HTS efforts, demonstrating excellent plate Z′ values during the HTS campaign (0.84 ± 0.03; 0.72 ± 0.05 for LK and TR-FRET campaigns, respectively). Both formats identified scaffolds of known and novel ROCK-II inhibitors with similar sensitivity. A comparison of the performance of these 2 assay formats in an HTS campaign was enabled by the existence of a subset of 25,000 compounds found in both our institutional and the Molecular Library Screening Center Network screening files. Analysis of the HTS campaign results based on this subset of common compounds showed that both formats had comparable total hit rates, hit distributions, amount of hit clusters, and format-specific artifact. It can be concluded that both assay formats are suitable for the discovery of ROCK-II inhibitors, and the choice of assay format depends on reagents and/or screening technology available.

Original languageEnglish
Pages (from-to)17-28
Number of pages12
JournalJournal of Biomolecular Screening
Volume13
Issue number1
DOIs
StatePublished - Feb 1 2008
Externally publishedYes

Fingerprint

High-Throughput Screening Assays
rho-Associated Kinases
Fluorescence Resonance Energy Transfer
Luciferases
Assays
Screening
Phosphotransferases
Throughput
Enzymes
Inhibitory Concentration 50
Drug Discovery
Luminescence
Artifacts
Adenosine Triphosphate
Pharmacology
Metabolism
Scaffolds
Technology
Research

Keywords

  • High-throughput screening
  • Homogeneous time-resolved fluorescence
  • HTS
  • Kinase assays
  • Kinase Glo
  • Luminescence
  • MLSCN
  • NIH Roadmap initiative
  • Rho-associated kinase II
  • rhoK2
  • ROCK-II
  • rock2

ASJC Scopus subject areas

  • Analytical Chemistry
  • Clinical Biochemistry
  • Biotechnology
  • Biochemistry
  • Molecular Biology

Cite this

Comparison of miniaturized time-resolved fluorescence resonance energy transfer and enzyme-coupled luciferase high-throughput screening assays to discover inhibitors of Rho-kinase II (ROCK-II). / Schröter, Thomas; Minond, Dmitriy; Weiser, Amiee; Dao, Chinh; Habel, Jeff; Spicer, Timothy; Chase, Peter; Baillargeon, Pierre; Scampavia, Louis; Schuerer, Stephan C; Chung, Caty; Mader, Chris; Southern, Mark; Tsinoremas, Nicholas; LoGrasso, Philip; Hodder, Peter.

In: Journal of Biomolecular Screening, Vol. 13, No. 1, 01.02.2008, p. 17-28.

Research output: Contribution to journalArticle

Schröter, T, Minond, D, Weiser, A, Dao, C, Habel, J, Spicer, T, Chase, P, Baillargeon, P, Scampavia, L, Schuerer, SC, Chung, C, Mader, C, Southern, M, Tsinoremas, N, LoGrasso, P & Hodder, P 2008, 'Comparison of miniaturized time-resolved fluorescence resonance energy transfer and enzyme-coupled luciferase high-throughput screening assays to discover inhibitors of Rho-kinase II (ROCK-II)', Journal of Biomolecular Screening, vol. 13, no. 1, pp. 17-28. https://doi.org/10.1177/1087057107310806
Schröter, Thomas ; Minond, Dmitriy ; Weiser, Amiee ; Dao, Chinh ; Habel, Jeff ; Spicer, Timothy ; Chase, Peter ; Baillargeon, Pierre ; Scampavia, Louis ; Schuerer, Stephan C ; Chung, Caty ; Mader, Chris ; Southern, Mark ; Tsinoremas, Nicholas ; LoGrasso, Philip ; Hodder, Peter. / Comparison of miniaturized time-resolved fluorescence resonance energy transfer and enzyme-coupled luciferase high-throughput screening assays to discover inhibitors of Rho-kinase II (ROCK-II). In: Journal of Biomolecular Screening. 2008 ; Vol. 13, No. 1. pp. 17-28.
@article{6d750dcea53c4318a6d1bdcf4c37cbf7,
title = "Comparison of miniaturized time-resolved fluorescence resonance energy transfer and enzyme-coupled luciferase high-throughput screening assays to discover inhibitors of Rho-kinase II (ROCK-II)",
abstract = "Kinases are important drug discovery targets for a wide variety of therapeutic indications; consequently, the measurement of kinase activity remains a common high-throughput screening (HTS) application. Recently, enzyme-coupled luciferase-kinase (LK) format assays have been introduced. This format measures luminescence resulting from metabolism of adenosine triphosphate (ATP) via a luciferin/luciferase-coupled reaction. In the research presented here, 1536-well format time-resolved fluorescence resonance energy transfer (TR-FRET) and LK assays were created to identify novel Rho-associated kinase II (ROCK-II) inhibitors. HTS campaigns for both assays were conducted in this miniaturized format. It was found that both assays were able to consistently reproduce the expected pharmacology of inhibitors known to be specific to ROCK-II (fasudil IC50: 283 ± 27 nM and 336 ± 54 nM for TR-FRET and LK assays, respectively; Y-27632 IC50: 133 ± 7.8 nM and 150 ± 22 nM for TR-FRET and LK assays, respectively). In addition, both assays proved robust for HTS efforts, demonstrating excellent plate Z′ values during the HTS campaign (0.84 ± 0.03; 0.72 ± 0.05 for LK and TR-FRET campaigns, respectively). Both formats identified scaffolds of known and novel ROCK-II inhibitors with similar sensitivity. A comparison of the performance of these 2 assay formats in an HTS campaign was enabled by the existence of a subset of 25,000 compounds found in both our institutional and the Molecular Library Screening Center Network screening files. Analysis of the HTS campaign results based on this subset of common compounds showed that both formats had comparable total hit rates, hit distributions, amount of hit clusters, and format-specific artifact. It can be concluded that both assay formats are suitable for the discovery of ROCK-II inhibitors, and the choice of assay format depends on reagents and/or screening technology available.",
keywords = "High-throughput screening, Homogeneous time-resolved fluorescence, HTS, Kinase assays, Kinase Glo, Luminescence, MLSCN, NIH Roadmap initiative, Rho-associated kinase II, rhoK2, ROCK-II, rock2",
author = "Thomas Schr{\"o}ter and Dmitriy Minond and Amiee Weiser and Chinh Dao and Jeff Habel and Timothy Spicer and Peter Chase and Pierre Baillargeon and Louis Scampavia and Schuerer, {Stephan C} and Caty Chung and Chris Mader and Mark Southern and Nicholas Tsinoremas and Philip LoGrasso and Peter Hodder",
year = "2008",
month = "2",
day = "1",
doi = "10.1177/1087057107310806",
language = "English",
volume = "13",
pages = "17--28",
journal = "Journal of Biomolecular Screening",
issn = "1087-0571",
publisher = "SAGE Publications Inc.",
number = "1",

}

TY - JOUR

T1 - Comparison of miniaturized time-resolved fluorescence resonance energy transfer and enzyme-coupled luciferase high-throughput screening assays to discover inhibitors of Rho-kinase II (ROCK-II)

AU - Schröter, Thomas

AU - Minond, Dmitriy

AU - Weiser, Amiee

AU - Dao, Chinh

AU - Habel, Jeff

AU - Spicer, Timothy

AU - Chase, Peter

AU - Baillargeon, Pierre

AU - Scampavia, Louis

AU - Schuerer, Stephan C

AU - Chung, Caty

AU - Mader, Chris

AU - Southern, Mark

AU - Tsinoremas, Nicholas

AU - LoGrasso, Philip

AU - Hodder, Peter

PY - 2008/2/1

Y1 - 2008/2/1

N2 - Kinases are important drug discovery targets for a wide variety of therapeutic indications; consequently, the measurement of kinase activity remains a common high-throughput screening (HTS) application. Recently, enzyme-coupled luciferase-kinase (LK) format assays have been introduced. This format measures luminescence resulting from metabolism of adenosine triphosphate (ATP) via a luciferin/luciferase-coupled reaction. In the research presented here, 1536-well format time-resolved fluorescence resonance energy transfer (TR-FRET) and LK assays were created to identify novel Rho-associated kinase II (ROCK-II) inhibitors. HTS campaigns for both assays were conducted in this miniaturized format. It was found that both assays were able to consistently reproduce the expected pharmacology of inhibitors known to be specific to ROCK-II (fasudil IC50: 283 ± 27 nM and 336 ± 54 nM for TR-FRET and LK assays, respectively; Y-27632 IC50: 133 ± 7.8 nM and 150 ± 22 nM for TR-FRET and LK assays, respectively). In addition, both assays proved robust for HTS efforts, demonstrating excellent plate Z′ values during the HTS campaign (0.84 ± 0.03; 0.72 ± 0.05 for LK and TR-FRET campaigns, respectively). Both formats identified scaffolds of known and novel ROCK-II inhibitors with similar sensitivity. A comparison of the performance of these 2 assay formats in an HTS campaign was enabled by the existence of a subset of 25,000 compounds found in both our institutional and the Molecular Library Screening Center Network screening files. Analysis of the HTS campaign results based on this subset of common compounds showed that both formats had comparable total hit rates, hit distributions, amount of hit clusters, and format-specific artifact. It can be concluded that both assay formats are suitable for the discovery of ROCK-II inhibitors, and the choice of assay format depends on reagents and/or screening technology available.

AB - Kinases are important drug discovery targets for a wide variety of therapeutic indications; consequently, the measurement of kinase activity remains a common high-throughput screening (HTS) application. Recently, enzyme-coupled luciferase-kinase (LK) format assays have been introduced. This format measures luminescence resulting from metabolism of adenosine triphosphate (ATP) via a luciferin/luciferase-coupled reaction. In the research presented here, 1536-well format time-resolved fluorescence resonance energy transfer (TR-FRET) and LK assays were created to identify novel Rho-associated kinase II (ROCK-II) inhibitors. HTS campaigns for both assays were conducted in this miniaturized format. It was found that both assays were able to consistently reproduce the expected pharmacology of inhibitors known to be specific to ROCK-II (fasudil IC50: 283 ± 27 nM and 336 ± 54 nM for TR-FRET and LK assays, respectively; Y-27632 IC50: 133 ± 7.8 nM and 150 ± 22 nM for TR-FRET and LK assays, respectively). In addition, both assays proved robust for HTS efforts, demonstrating excellent plate Z′ values during the HTS campaign (0.84 ± 0.03; 0.72 ± 0.05 for LK and TR-FRET campaigns, respectively). Both formats identified scaffolds of known and novel ROCK-II inhibitors with similar sensitivity. A comparison of the performance of these 2 assay formats in an HTS campaign was enabled by the existence of a subset of 25,000 compounds found in both our institutional and the Molecular Library Screening Center Network screening files. Analysis of the HTS campaign results based on this subset of common compounds showed that both formats had comparable total hit rates, hit distributions, amount of hit clusters, and format-specific artifact. It can be concluded that both assay formats are suitable for the discovery of ROCK-II inhibitors, and the choice of assay format depends on reagents and/or screening technology available.

KW - High-throughput screening

KW - Homogeneous time-resolved fluorescence

KW - HTS

KW - Kinase assays

KW - Kinase Glo

KW - Luminescence

KW - MLSCN

KW - NIH Roadmap initiative

KW - Rho-associated kinase II

KW - rhoK2

KW - ROCK-II

KW - rock2

UR - http://www.scopus.com/inward/record.url?scp=37749050446&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37749050446&partnerID=8YFLogxK

U2 - 10.1177/1087057107310806

DO - 10.1177/1087057107310806

M3 - Article

C2 - 18227223

AN - SCOPUS:37749050446

VL - 13

SP - 17

EP - 28

JO - Journal of Biomolecular Screening

JF - Journal of Biomolecular Screening

SN - 1087-0571

IS - 1

ER -